98 related articles for article (PubMed ID: 9149125)
1. p16 tumor suppressor gene mutations in Chinese esophageal carcinomas in Hong Kong.
Chan WC; Tang CM; Lau KW; Lung ML
Cancer Lett; 1997 May; 115(2):201-6. PubMed ID: 9149125
[TBL] [Abstract][Full Text] [Related]
2. Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas.
Esteve A; Martel-Planche G; Sylla BS; Hollstein M; Hainaut P; Montesano R
Int J Cancer; 1996 May; 66(3):301-4. PubMed ID: 8621247
[TBL] [Abstract][Full Text] [Related]
3. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
4. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China.
Lung ML; Chan WC; Zong YS; Tang CM; Fok CL; Wong KT; Chan LK; Lau KW
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):277-84. PubMed ID: 8722219
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
6. Multiple types of aberrations in the p16 (INK4a) and the p15(INK4b) genes in 30 esophageal squamous-cell-carcinoma cell lines.
Tanaka H; Shimada Y; Imamura M; Shibagaki I; Ishizaki K
Int J Cancer; 1997 Feb; 70(4):437-42. PubMed ID: 9033652
[TBL] [Abstract][Full Text] [Related]
7. Absence of p16/MTS1 gene mutations in human prostate cancer.
Chen W; Weghorst CM; Sabourin CL; Wang Y; Wang D; Bostwick DG; Stoner GD
Carcinogenesis; 1996 Dec; 17(12):2603-7. PubMed ID: 9006095
[TBL] [Abstract][Full Text] [Related]
8. Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers.
Suzuki H; Zhou X; Yin J; Lei J; Jiang HY; Suzuki Y; Chan T; Hannon GJ; Mergner WJ; Abraham JM
Hum Mol Genet; 1995 Oct; 4(10):1883-7. PubMed ID: 8595411
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.
Xing EP; Nie Y; Wang LD; Yang GY; Yang CS
Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853
[TBL] [Abstract][Full Text] [Related]
10. Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma.
El-Naggar AK; Lai S; Clayman G; Lee JK; Luna MA; Goepfert H; Batsakis JG
Am J Pathol; 1997 Dec; 151(6):1767-74. PubMed ID: 9403727
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers.
Muzeau F; Fléjou JF; Thomas G; Hamelin R
Int J Cancer; 1997 Jul; 72(1):27-30. PubMed ID: 9212218
[TBL] [Abstract][Full Text] [Related]
12. Absence of p16 gene (CDKN2) deletions in microdissected primary breast carcinoma specimens.
Calvano JE; Rush EB; Tan LK; Rosen PP; Borgen PI; Van Zee KJ
Ann Surg Oncol; 1997; 4(5):416-20. PubMed ID: 9259969
[TBL] [Abstract][Full Text] [Related]
13. [Detection of mutation in exon 5 and exon 8 of PTEN in laryngeal squamous cell carcinoma].
Bai WL; Gao H; Ren Z; Pan ZM
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 39(1):13-6. PubMed ID: 15127561
[TBL] [Abstract][Full Text] [Related]
14. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
[TBL] [Abstract][Full Text] [Related]
15. High frequency of homozygous deletion and methylation of p16(INK4A) gene in oral squamous cell carcinomas.
Nakahara Y; Shintani S; Mihara M; Ueyama Y; Matsumura T
Cancer Lett; 2001 Feb; 163(2):221-8. PubMed ID: 11165758
[TBL] [Abstract][Full Text] [Related]
16. Analysis of p16 gene deletion and point mutation in breast carcinoma.
Quesnel B; Fenaux P; Philippe N; Fournier J; Bonneterre J; Preudhomme C; Peyrat JP
Br J Cancer; 1995 Aug; 72(2):351-3. PubMed ID: 7640217
[TBL] [Abstract][Full Text] [Related]
17. MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines.
Liu Q; Yan YX; McClure M; Nakagawa H; Fujimura F; Rustgi AK
Oncogene; 1995 Feb; 10(3):619-22. PubMed ID: 7845688
[TBL] [Abstract][Full Text] [Related]
18. p16/CDKN2 alterations and pRb expression in oesophageal squamous carcinoma.
Busatto G; Shiao YH; Parenti AR; Baffa R; Ruol A; Plebani M; Rugge M
Mol Pathol; 1998 Apr; 51(2):80-4. PubMed ID: 9713590
[TBL] [Abstract][Full Text] [Related]
19. The MTS1 gene is frequently mutated in primary human esophageal tumors.
Zhou X; Tarmin L; Yin J; Jiang HY; Suzuki H; Rhyu MG; Abraham JM; Meltzer SJ
Oncogene; 1994 Dec; 9(12):3737-41. PubMed ID: 7970734
[TBL] [Abstract][Full Text] [Related]
20. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
